Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 161

1.

Decrease of FGF receptor (FGFR) and interstitial fibrosis in the kidney of streptozotocin-induced diabetic rats.

Cheng MF, Chen LJ, Wang MC, Hsu CT, Cheng JT.

Horm Metab Res. 2014 Jan;46(1):1-7. doi: 10.1055/s-0033-1349090. Epub 2013 Jul 4.

PMID:
23828126
2.

Decrease of Klotho in the kidney of streptozotocin-induced diabetic rats.

Cheng MF, Chen LJ, Cheng JT.

J Biomed Biotechnol. 2010;2010:513853. doi: 10.1155/2010/513853. Epub 2010 Jun 27.

3.

Rosiglitazone is effective to improve renal damage in type-1-like diabetic rats.

Huang KC, Cherng YG, Chen LJ, Hsu CT, Cheng JT.

Horm Metab Res. 2014 Apr;46(4):240-4. doi: 10.1055/s-0033-1357161. Epub 2013 Oct 17.

PMID:
24136780
4.

Decrease of bone morphogenetic protein-7 (BMP-7) and its type II receptor (BMP-RII) in kidney of type 1-like diabetic rats.

Yeh CH, Chang CK, Cheng MF, Lin HJ, Cheng JT.

Horm Metab Res. 2009 Aug;41(8):605-11. doi: 10.1055/s-0029-1220736. Epub 2009 May 13.

PMID:
19440953
5.

Spironolactone exhibits direct renoprotective effects and inhibits renal renin-angiotensin-aldosterone system in diabetic rats.

Taira M, Toba H, Murakami M, Iga I, Serizawa R, Murata S, Kobara M, Nakata T.

Eur J Pharmacol. 2008 Jul 28;589(1-3):264-71. doi: 10.1016/j.ejphar.2008.06.019. Epub 2008 Jun 10.

PMID:
18582458
6.

Growth factor ultrafiltration in experimental diabetic nephropathy contributes to interstitial fibrosis.

Wang SN, Hirschberg R.

Am J Physiol Renal Physiol. 2000 Apr;278(4):F554-60.

7.

Dickkopf-1 promotes hyperglycemia-induced accumulation of mesangial matrix and renal dysfunction.

Lin CL, Wang JY, Ko JY, Huang YT, Kuo YH, Wang FS.

J Am Soc Nephrol. 2010 Jan;21(1):124-35. doi: 10.1681/ASN.2008101059. Epub 2009 Dec 17.

8.

Effect of Lactobacillus reuteri GMNL-263 treatment on renal fibrosis in diabetic rats.

Lu YC, Yin LT, Chang WT, Huang JS.

J Biosci Bioeng. 2010 Dec;110(6):709-15. doi: 10.1016/j.jbiosc.2010.07.006. Epub 2010 Aug 5.

PMID:
20691633
9.

Increase of ATP-sensitive potassium (K(ATP)) channels in the heart of type-1 diabetic rats.

Chen ZC, Cheng YZ, Chen LJ, Cheng KC, Li Y, Cheng J.

Cardiovasc Diabetol. 2012 Jan 18;11:8. doi: 10.1186/1475-2840-11-8.

10.

Hyperglycemia induced down-regulation of renal P-glycoprotein expression.

Yeh SY, Pan HJ, Lin CC, Kao YH, Chen YH, Lin CJ.

Eur J Pharmacol. 2012 Sep 5;690(1-3):42-50. doi: 10.1016/j.ejphar.2012.06.013. Epub 2012 Jun 18.

PMID:
22721613
11.

Tubular overexpression of Gremlin in transgenic mice aggravates renal damage in diabetic nephropathy.

Marchant V, Droguett A, Valderrama G, Burgos ME, Carpio D, Kerr B, Ruiz-Ortega M, Egido J, Mezzano S.

Am J Physiol Renal Physiol. 2015 Sep 15;309(6):F559-68. doi: 10.1152/ajprenal.00023.2015. Epub 2015 Jul 8.

12.

Effects of linalool on inflammation, matrix accumulation and podocyte loss in kidney of streptozotocin-induced diabetic rats.

Deepa B, Venkatraman Anuradha C.

Toxicol Mech Methods. 2013 May;23(4):223-34. doi: 10.3109/15376516.2012.743638. Epub 2013 Jan 16.

PMID:
23193997
13.

Metformin attenuates streptozotocin-induced diabetic nephropathy in rats through modulation of oxidative stress genes expression.

Alhaider AA, Korashy HM, Sayed-Ahmed MM, Mobark M, Kfoury H, Mansour MA.

Chem Biol Interact. 2011 Jul 15;192(3):233-42. doi: 10.1016/j.cbi.2011.03.014. Epub 2011 Mar 30.

PMID:
21457706
14.

Characterization of the development of renal injury in Type-1 diabetic Dahl salt-sensitive rats.

Slaughter TN, Paige A, Spires D, Kojima N, Kyle PB, Garrett MR, Roman RJ, Williams JM.

Am J Physiol Regul Integr Comp Physiol. 2013 Oct 1;305(7):R727-34. doi: 10.1152/ajpregu.00382.2012. Epub 2013 Aug 7.

15.
16.

Protective effect of esculetin on hyperglycemia-mediated oxidative damage in the hepatic and renal tissues of experimental diabetic rats.

Prabakaran D, Ashokkumar N.

Biochimie. 2013 Feb;95(2):366-73. doi: 10.1016/j.biochi.2012.10.008. Epub 2012 Oct 16.

PMID:
23079336
17.

Diabetes-induced upregulation of urotensin II and its receptor plays an important role in TGF-beta1-mediated renal fibrosis and dysfunction.

Tian L, Li C, Qi J, Fu P, Yu X, Li X, Cai L.

Am J Physiol Endocrinol Metab. 2008 Nov;295(5):E1234-42. doi: 10.1152/ajpendo.90672.2008. Epub 2008 Sep 16.

18.

Tubular and interstitial cell apoptosis in the streptozotocin-diabetic rat kidney.

Kumar D, Zimpelmann J, Robertson S, Burns KD.

Nephron Exp Nephrol. 2004;96(3):e77-88.

PMID:
15056984
19.

Molecular role of GATA binding protein 4 (GATA-4) in hyperglycemia-induced reduction of cardiac contractility.

Ku PM, Chen LJ, Liang JR, Cheng KC, Li YX, Cheng JT.

Cardiovasc Diabetol. 2011 Jun 24;10:57. doi: 10.1186/1475-2840-10-57.

20.

Immunolocalization of fibroblast growth factor-1 (FGF-1), its receptor (FGFR-1), and fibroblast-specific protein-1 (FSP-1) in inflammatory renal disease.

Rossini M, Cheunsuchon B, Donnert E, Ma LJ, Thomas JW, Neilson EG, Fogo AB.

Kidney Int. 2005 Dec;68(6):2621-8.

Supplemental Content

Support Center